Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Publication year
2018Author(s)
Source
Lancet Oncology, 19, 3, (2018), pp. 295-309ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Oncology
Radiation Oncology
Journal title
Lancet Oncology
Volume
vol. 19
Issue
iss. 3
Page start
p. 295
Page end
p. 309
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [204994]
- Electronic publications [103280]
- Faculty of Medical Sciences [81051]
- Open Access publications [71810]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.